SCHEMBL6177544

SCHEMBL6177544

CN(C)C(=O)N1CC(NC(=O)OC(C)(C)C)C(=O)Nc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.44
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
GAA P10253 1/20 0.40
PIM1 P11309 1/20 0.40
PIM3 Q86V86 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
IDO1 P14902 1/20 0.39
MAPK10 P53779 1/20 0.38
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SCN9A Q15858 1/20 0.36
CCKAR P32238 1/20 0.35
CCKBR P32239 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176634 0.88 EPHX2 (0.46) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6177724 0.88 EPHX2 (0.44) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6175654 0.87 EPHX2 (0.46) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6176374 0.87 EPHX2 (0.46) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL15799246 0.86 EPHX2 (0.45) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6175840 0.86 EPHX2 (0.45) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6179436 0.85 HTT (0.48) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6178399 0.84 EPHX2 (0.43) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6179544 0.84 CASP3 (0.49) EPHX2HDAC2HDAC8HDAC6GAA
SCHEMBL6176160 0.84 IDH1 (0.45) EPHX2HDAC2HDAC8HDAC6GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed